| Name | Title | Contact Details |
|---|
Semper Laser is a laser hair removal company that specializes in providing affordable and advanced laser hair removal treatments for both men and women.
Molina Healthcare of Michigan is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medco is a leading pharmacy benefit manager (PBM), with the nation's largest mail order pharmacy operations. Medco Pharmacy operates 10 mail-order pharmacies and partners with a nationwide network of approximately 60,000 retail pharmacies. Medco’s automated pharmacies located in Las Vegas, Indianapolis, and Willingboro, NJ, together have the capacity to fill more than 3 million prescriptions per week. Medco Health Solutions, Inc. is an American Pharmacy Benefits Management (PBM) company currently serving the needs of more than 65 million people. Medco provides pharmacy services for private and public employers, health plans, labor unions, government agencies, and individuals served by Medicare Part D Prescription Drug Plans. Medco is a member of the S&P 500 and is ranked number 34 on the 2011 Fortune 500 list, with 2011 revenues of more than $70 billion. It has earned the No. 1 ranking in the Healthcare: Pharmacy and Other Services category on Fortune magazine’s World’s Most Admired Companies list for five consecutive years (2008-2012). Medco was originally founded as National Pharmacies in 1983. In 1984, after an IPO, National Pharmacies became Medco Containment Services, LLC. In 1990, Medco Containment was acquired by Merck & Co., Inc. and became Merck-Medco. In August 2003, Medco Health Solutions, Inc. became an independent company in one of the largest domestic spin-offs at the time. It has recently been acquired by Express Scripts
Giuseppe Space Enterprises is a company that specializes in the implementation, integration, and optimization of various tools and technologies into standardized system engineering/integration processes and workflows. They are committed to advancing th...
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODITâ„¢ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODITâ„¢ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.